TORONTO, ON / ACCESSWIRE / February 25, 2019 / Pelangio Exploration Inc. (PX:TSX-V; OTC PINK:PGXPF) (“Pelangio” or the “Company”) is pleased to provide an exploration update on three of its highly prospective Canadian projects. The Dome West and Dalton properties are strategically located in the Timmins mining camp and the Montcalm properties are located in proximity to Glencore’s Montcalm Mine Property (see Maps 1, 2 & 3 below).

Highlights

Dome West Property (800 metres (“m”) west of the Dome Mine):

diamond drilling to begin in April

two target areas for diamond drilling identified

access agreement to the property with Goldcorp Inc. well underway

Dalton Property (1.5 kilometres (“km”) SW of the historic Hollinger Gold Mine):

geophysical surveying, geochemical sampling and prospecting during the 2019 summer field season

sampling and assessment of historical drill core, surface pits and trenches identified substantial alteration and sulphide mineralization

diamond drilling planned for autumn 2019

Montcalm Area Nickel Cobalt Copper Properties:

4500m drilling program underway by Pancontinental Resources Corporation on the Pancontinental/ Pelangio Project under option from Pelangio and located adjacent to the former Glencore Montcalm Mine

Pelangio optioned the Strachan property to Pancontinental in January 2019

“We are very pleased to have begun our initial investigations of the newly acquired Dome West and Dalton gold properties, with diamond drilling slated to begin on the Dome West property in April,” commented Ingrid Hibbard, President and CEO of Pelangio. “Our Timmins camp projects offer great potential due to their proximity to historical producing mines. We look forward to continued exploration activity in 2019 with diamond drilling at Dome West, Dalton, and Montcalm as well as further target generation at both Dome West and Dalton.”

Dome West Project

Pelangio acquired the option on the Dome West Property in late January, 2019 (see press release January 22, 2019).The Dome West property, formerly controlled by Central Porcupine Mines Ltd., is a strategic land holding that is adjacent to both the former Paymaster Mine property and Goldcorp’s Dome Mine (Source: Ont. Dept of Mines Map 449B, Ferguson, 1969). More specifically, the Dome West property is located approximately 800 metres west of the Dome Mine (See Maps 1 and 2 below). In fact, the property is in such close proximity to the Dome Mine, that access to Pelangio’s property is via Goldcorp’s Dome Mine surface holdings.

Upon acquiring the Dome West property, the project’s historical data underwent a technical review. This review of the limited data available has shown two main target areas of interest. Currently the highest priority target is Target P1, a highly prospective porphyritic sill unit interpreted to extend across a substantial portion of the Dome West property at the 1000-foot elevation from the former Paymaster Mine property (Source: Ontario Dept of Mines Map 449B, Ferguson, 1969 and OGS Assessment File T-125). A second target area of interest is present in the central portion of the property where government geologists have documented a historical shaft and a small adit associated with quartz veins in outcrop (reference: Ontario Dept of Mines Map Map 2075).

Early in February, a property visit was completed to evaluate access to the property and facilitate an access agreement with Goldcorp. Given the extremely challenging topography for ground access to the P1 target area, it was determined that the best cost-effective and environmentally sound solution was to utilize helicopter support for the diamond drill program on the P1 target. Pelangio is grateful to Goldcorp for their support and ongoing consultation to reach this solution.

Subject to the completion of the access agreement and securing a helicopter drill rig, Pelangio anticipates initiating testing of the P1 target in April.

With the exception of some geophysical surveying in recent years, very limited exploration work has been conducted on the Dome West Property since the late 1940’s. Pelangio intends to continue investigating this highly prospective property to develop additional drill targets utilizing modern exploration geochemical and geophysical surveying techniques where applicable.

Map 1: Location of the Dalton and Dome West property in reference to historical mines in the Timmins Camp

(To view the full-size image, please click here)

Dalton Property:

Pelangio’s Dalton Property is located approximately 1.5 km SW of the historic Hollinger Gold Mine currently being operated as an open pit operation by Goldcorp (see Maps 1 and 2).In the late fall of 2018, Pelangio completed sampling of historical drill core and a number of surface pits and trenches located on the eastern extremity of the property. Substantial alteration and sulphide mineralization were observed in the samples suggesting a very prospective environment for gold mineralization, although the sampling program did not return any significant gold results.

A series of shear zones observed on the property trend in an east-west direction and all of the historical drill holes recently sampled by Pelangio were oriented parallel to these shear zones. As such, these drill holes did not adequately evaluate the potential gold bearing shear zones or structures. For minimal cost, this sampling allowed Pelangio to establish the existence of a favourable environment for gold deposition demonstrated by substantial alteration and sulphide mineralization on areas of the property with no outcrop exposure.

Early in the 2019 field season Pelangio intends to conduct a detailed state of the art geochemical sampling and geophysical surveying to outline potential targets at depth on the property. The majority of historical work on this property was from surface to an approximate vertical depth of 150m leaving significant untested potential at depth.

Map 2: Regional geology of the Timmins area showing the location of the Dome West and Dalton properties in relation to the Dome and Hollinger Mines

(To view the full-size image, please click here)

Montcalm Area Holdings

Aside from Pelangio’s primary Canadian gold projects, it also owns an interest in a number of prospective mineral claims proximal to Glencore’s former Montcalm nickel, copper, cobalt mine (See Map 3 below), located approximately 65 km NW of the City of Timmins. These claims comprise the Montcalm and Nova properties as well as the recently optioned Strachan property (see press release January 18, 2019).All three properties are under option to Pancontinental Resources and provide Pelangio with exposure to a significant battery metals exploration program. In the event that Pancontinental fully exercises its options on the properties, Pelangio will maintain exposure to exploration success through the share issuances from Pancontinental as well as Pelangio’s remaining 25% interest in Strachan and the residual royalties on the Montcalm and Nova properties. Pancontinental is currently conducting a winter drilling campaign on Pelangio’s Montcalm property adjacent to Glencore’s Montcalm Mine Property.

Map #3: Location of the Strachan property in reference to the Montcalm Mine and the Montcalm and Nova projects

(To view the full-size image, please click here)

Qualified Person

Mr. Kevin Filo, P.Geo. (Ontario), is a qualified person within the meaning of National Instrument 43-101. Mr. Filo has verified and approved the data disclosed in this release.

About Pelangio

Pelangio acquires and explores large land packages in world-class gold belts in Canada and Ghana, West Africa. In Canada, the company is focusing on the Dome West property located 800 metres from the Dome Mine in Timmins, the 25 km2 Birch Lake Property located in the Red Lake Mining District and the Dalton Property located 1.5 km from the Hollinger mine in Timmins. In Ghana, the Company is focusing on two 100%- owned camp-sized properties: the 100 km2 Manfo Property, the site of seven recent near-surface gold discoveries, and the 284 km2 Obuasi Property, located 4 km on strike and adjacent to AngloGold Ashanti’s prolific high-grade Obuasi Mine. Ghana is an English-speaking, common law jurisdiction that is consistently ranked amongst the most favourable mining jurisdictions in Africa.

For additional information, please visit our website at www.pelangio.com, or contact:

Ingrid Hibbard, President and CEO

Tel: 905-336-3828 / Toll-free: 1-877-746-1632 / Email: info@pelangio.com

Forward Looking Statements

Certain statements herein may contain forward-looking statements and forward-looking information within the meaning of applicable securities laws. Forward-looking statements or information appear in a number of places and can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate” or “believes” or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements and information include statements regarding the Company’s ability to complete the planned work programs, the Company’s strategy of acquiring large land packages in areas of sizable gold mineralization, the Company’s plans to follow-up on previous work, and the Company’s exploration plans. With respect to forward-looking statements and information contained herein, we have made numerous assumptions, including assumptions about the state of the equity markets. Such forward-looking statements and information are subject to risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statement or information. Such risks include the changes in equity markets, share price volatility, volatility of global and local economic climate, gold price volatility, increases in costs, exchange rate fluctuations, speculative nature of gold exploration and other risks involved in the gold exploration industry, including the risk that favourable results may not be obtained. See the Company’s annual and quarterly financial statements and management’s discussion and analysis for additional information on risks and uncertainties relating to the forward-looking statement and information. There can be no assurance that a forward-looking statement or information referenced herein will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements or information. Also, many of the factors are beyond the control of the Company. Accordingly, readers should not place undue reliance on forward- looking statements or information. We undertake no obligation to reissue or update any forward-looking statements or information except as required by law. All forward-looking statements and information herein are qualified by this cautionary statement.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Pelangio Exploration Inc.

ReleaseID: 536841

CHICAGO, IL / ACCESSWIRE / February 25, 2019 / Chicago, one of the biggest hubs of the finance industry is now getting an agile transaction service at the speed of “Lite.” As long as as one has access to a digital wallet, you can access cash capital for the cryptocurrency you currently have.

Bitcoin Depot, the 2nd largest Bitcoin ATM service in the world had added about three ATMs to Chicago a year ago, and now will be releasing 30 more ATMs throughout 2019 — with the expansion to hit 50 ATMs by 2020. This will bring the company, which has currently 150 ATMs to 180 ATMs. There are some ATMs that are notable in the Chicago space that only trade in Bitcoin – however despite their company name; Bitcoin Depot also trades in Litecoin, Ethereum, and Bitcoin Cash.

Nearly all of the company’s Bitcoin ATM locations in the Chicago area are in 24/7 convenience stores spread throughout the city so that it can provide easy access to the nearly 10 million people in the Chicago metro area.

It’s been a wild year for crypto as the volatility has left users wary of the market. Many not familiar with the usages of Blockchain, and tend to see tokenization of currency as a fad that’s not substantive nor backed by a specific currency — will definitely be interested to see how these ATMs continue to grow in giving immediate cash for coins.

This year marks the 10-year anniversary of Bitcoin, imagine what 10 more years will bring.

Brandon Mintz, CEO of Bitcoin Depot has stated, “We want to encourage as many people as we can in Chicago to try one of our Bitcoin ATMs, so they can see for themselves how quick and simple it is to buy Bitcoin from us. By offering a zero fee promotion (for a limited time) Bitcoin Depot hopes that consumers, who have been on the fence about buying Bitcoin will now be more inclined to give it a try. To be eligible for zero fees, customers will need to sign up on our website BitcoinDepot.com with promo code “Chi Town” prior to visiting one of our Bitcoin ATMs.”

CONTACT:

Hoang Nguyen, 240-620-9652

SOURCE: Bitcoin Depot

ReleaseID: 536838

Hello Investor:

VANCOUVER, BC / ACCESSWIRE / February 25, 2019 / Belmont Resources Inc. (TSX.V: BEA; FSE: L3L1 will be exhibiting at the Prospectors and Developers Association of Canada Convention (PDAC) – Metro Toronto Convention Centre, 255 Front St. W., Toronto, Ontario – Sunday March 3, 2019 to Wednesday March 6, 2019.

We would like to invite you to meet the Belmont Resources team at Booth #2819 celebrating 40+ years of being in business.

Belmont Resources Inc. (TSX.V: BEA)

Exhibit Hours – South Building, Level 800
Sunday, March 3 – 10:00 a.m. – 5:00 p.m.
Monday, March 4 – 10:00 a.m. – 5:00 p.m.
Tuesday, March 5 – 10:00 a.m. – 5:00 p.m.
Wednesday, March 6 – 9:00 a.m. – 12:00 p.m.

PDAC is proud to be the leading voice of Canada’s mineral exploration and development community since 1932. Following a hugely successful PDAC 2018 Convention which welcomed more than 25,000 attendees from 135 countries, there are big expectations for 2019. The PDAC will provide current and prospective investors an opportunity to speak with management and consultants about the Company’s active Kibby Basin, Nevada Lithium project. Pick up your free copy of the latest Rockstone Research Report #20.

If you have any questions, feel free to contact the office at 604-683-6648.

Sincerely,

Gary Musil,
Corporate Secretary/CFO/Director
Email: gmusil@belmontresources.com

About Belmont Resources Inc.

Belmont is an emerging resource company engaged in the acquisition, exploration and development of mineral properties in Canada and Nevada, U.S.A.

For further information see our Website at: www.BelmontResources.com
-Facebook https://www.facebook.com/Nevadalithium/
-Twitter https://twitter.com/Belmont_Res

Belmont owns the Kibby Basin Lithium project covering 2,056 hectares (5,080 acres) in Esmeralda County, Nevada, U.S.A. The Kibby Basin property is located 65 km north of Clayton Valley, Nevada the location of the only US Lithium producer. MGX Minerals Inc. (CSE: XMG) has currently earned a 25% interest in the Kibby project and has the right to increase this to 50% by expending an additional $300,000 and become the operator.

In 50/50 ownership with International Montoro Resources Inc., Belmont has acquired and is exploring joint venture opportunities for its significant Uranium properties (Crackingstone -982 ha) in the Uranium City District in Northern Saskatchewan, Canada

ON BEHALF OF THE BOARD OF DIRECTORS

“James H. Place”
James (Jim) H. Place,
CEO/President/Director

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Belmont Resources Inc.

ReleaseID: 536844

NEW YORK, NY / ACCESSWIRE / February 25, 2019 / RealPage, Inc. (NASDAQ: RP) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on February 25, 2019 at 5:00 PM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/C-EFC6507C2B97E

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 536430

TORONTO, ON / ACCESSWIRE / February 25, 2019 / Toronto based CO2 GRO Inc. (”GROW”) (TSX-V: GROW, OTCQB: BLONF, Frankfurt: 4021) is pleased to provide further dramatic results from scientific pathogen experiments using CO2 Foliar Spray at two separate U.S. commercial cannabis greenhouses on cannabis sativa plants. These commercial growers financially supported this research.

All experiments were designed and measured consistent with GROW’s Pathogen experiments on peppers that were press released December 6, 2018. Results:

E. coli – Another excellent result of a two order of magnitude reduction in E.coli bacterial growth (99%) in the CO2 Foliar Sprayed cannabis plant group versus the control cannabis plant group. All plants were exposed to the E.Coli bacteria. Results are consistent with GROW’s pepper results.

Powdery Mildew – All plants were covered with a known dried powdery mildew pathogen and grown for a further 21 days. Results were scored visually at these commercial sites. All six plants in the control group developed powdery mildew disease while none of the CO2 Foliar Sprayed cannabis plants developed powdery mildew.

Grower Implications – CO2 Foliar Spray is gaining traction with commercial agreements and more successful plant science and trial data. According to Global Organics, the fastest growing acreage is organic, up 20% to 70M hectares Y-O-Y. CO2 Foliar Spray is proving to have some natural pathogen resistance that may lead to reduced need for chemical fungicides and pesticides and faster adoption by organic growers that cannot use them.

John Archibald, CEO, commented, ”We are delighted with the cannabis E. coli and powdery mildew results. Each trial adds to our collective knowledge. These U.S. cannabis results should have significant positive impact on our commercial endeavors.”

About CO2 GRO Inc.

GROW’s mission is to accelerate all indoor and outdoor value plant growth naturally, safely, and economically using its patent pending CO2 Foliar Spray technology. GROW’s global target retail plant markets are food at $8 trillion per year (Plunkett Mar 2017), non-food at an estimated $1.2 trillion per year with retail tobacco at $760 billion (BA Tobacco 2017), floriculture at $100 billion by 2022 (MarketResearch.Biz estimate). Legal cannabis at $52.5 billion per year by 2023 (Statista) and legal US hemp CBD at $22B per year by 2022 (the Brightfield Group).

GROW’s CO2 technologies are commercially proven, scalable and easily adopted into existing irrigation systems.

The CO2 technologies work by transferring CO2 gas into water and foliar spraying water across the entire plant leaf surface which is a semi permeable membrane. The dissolved concentrated CO2 then penetrates a leaf’s surface area naturally like nicotine dissolves through human skin from a soluble nicotine patch.

Foliar spraying of water, dissolved nutrients and chemicals on plant leaves has been used for over 60 years by millions of indoor and outdoor growers. To date, outdoor growers have not had any way to enhance plant CO2 gas uptake for faster growth.

Indoor CO2 gassing has enhanced plant yields for over 60 years but 60% of the CO2 gas used is typically lost from ventilation. Current greenhouse CO2 gassing levels of up to 1500 PPM are not ideal for worker health and safety. GROW’s safer infused CO2 Foliar Spray can be used by both indoor and outdoor plant growers with minimal dissolved CO2 gas lost and much greater CO2 plant bioavailability resulting in higher plant yields than both CO2 gassing and no gassing plant yields.

Forward-Looking Statements This news release may contain forward-looking statements that are based on CO2GRO’s expectations, estimates and projections regarding its business and the economic environment in which it operates. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. Statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For more information, please visit www.co2gro.ca or contact Sam Kanes, VP Business Development at 416-315-7477.

SOURCE: CO2GRO Inc.

ReleaseID: 536823

EMMEN, SWITZERLAND / ACCESSWIRE / February 25, 2019 / ALSO Group (SWX: ALSN):

ALSO successfully drives sustainable profitable growth forward

Group sales increased over-proportionally by 3.2 percent to 9.2 billion Euro
Adjusted EBITDA improved by 6.0 percent to 162.4 million Euro
Board of Directors proposes dividend increase to 3.00 CHF per share (+9.1 percent)

In 2018, the ALSO Group (SIX: ALSN) increased net sales in a slightly growing market (+1.7 percent) over-proportionally by 3.2 percent from 8.9 to 9.2 billion Euro. 90 percent of this growth was organic, primarily in Germany, France, Austria and in the Baltic States. An important growth driver was the promising IT-as-a-Service business with a sales increase of 36 percent. Adjusted for restructuring costs and currency effects, the ALSO Group achieved an EBITDA of 162.4 million Euro, compared to 153.2 million Euro in the previous year (+6.0 percent). Excluding this adjustment, reported EBITDA decreased from 157.3 million Euro to 152.7 million Euro.

For ALSO, 2018 was characterized by fundamental structural optimization. This was made possible on the one hand by investments in the Enterprise Resource Planning System (ERP), Business Intelligence Tools and Customer Relationship Management Systems (CRM), and on the other, by the consistent implementation of projects to improve and optimize business processes (Performance Improvement Program, Process Optimization Program). ALSO is thus pursuing the goal of sustainably increasing operational excellence and thus better aligning itself to market requirements and customer needs. At the same time, this opens up scope for further investments in the high-margin business models Solutions (IT architecture and design) and “as-a-Service” (logistics, IT and marketing-as-a-service).

In order to further increase profitability, ALSO will work intensively on the five steering levers (business model mix, vendor mix, reseller mix, product mix, operational excellence). In the area of operational excellence, the further digitization of the transactional business will be a key success factor. ALSO plans to harmonize the operating systems for the webshop and the ACMP (ALSO Cloud Marketplace) with the aim of using the findings from Business Intelligence to further increase sales and develop tailor-made solutions for customers, thereby strengthening customer loyalty. In addition, ALSO will continue to focus intensively on expanding its high-margin business models Solutions and “as-a-Service”.

In view of the increase in efficiency achieved and the positive development in areas of strategic importance to ALSO, the Group is confident to achieve further profitability improvements in the coming years. The Board of Directors will therefore propose to the Annual General Meeting on 29 March 2019 that the dividend be increased by CHF 0.25 to CHF 3.00 per share. The distribution will be made from reserves from capital contributions and is therefore tax-free for private investors. “Our MORE strategy, the long-term activities aimed at optimizing our traditional business and the consistent implementation of the other two business models have resulted in sustained profitable growth for ALSO in recent years, a growth which will continue,” stresses CEO Gustavo Möller-Hergt.

ALSO expects revenue growth in 2019 to exceed Gartner’s 0.9 percent market growth forecast. This growth will be driven by organic revenue growth through market share gains, the continued expansion of product categories and portfolio, as well as further development of the business models (Supply, Solutions and “as-a-Service”). ALSO will generate additional growth through acquisitions in its existing countries with the aim to further consolidate the market in the traditional distribution business and in companies active in the business models Solutions and “as-a-Service”. New countries within Europe will be developed through acquisitions and partnerships. These countries also play an important role in the international rollout of Platform-as-a-Service beyond Europe.

Reported EBITDA in 2019 is expected to improve by 10 to 15 million Euro year-on-year thanks to the increase in gross profit and the further optimization of costs. In the medium term, the ALSO Group is aiming for revenues of 10 to 14 billion Euro and an EBITDA margin of 2.1 to 2.6 percent.

Overview financial figures

MILLION EURO
2018
2017
Change

Net Sales
9 175.7
8 890.7
+3.2 %

EBITDA
152.7
157.3
-2.9 %

EBT
117.3
124.2
-5.6 %

Net Profit
81.2
92.5
-12.2 %

Net Financial Debt
163.1
173.7
-6.1 %

Cash flow before change of Net Working Capital
104.1
97.7
+6.6 %

Adjusted results

MILLION EURO
2018
2017
Change

EBITDA as reported
152.7
157.3
-2.9%

Currency Effects
-0.9
4.1

Extraordinary Cost for Structural Optimization
-8.8
–

EBITDA ADJUSTED
162.4
153.2
+6.0%

Change in the Board of Directors

After 23 years on the Board of Directors of ALSO Holding, Karl Hofstetter, member of the Board of Directors, will not be standing for re-election at the next Annual General Meeting on 29 March 2019. Gustavo Möller-Hergt, Chairman of the Board of Directors, comments: “We would like to thank Karl Hofstetter for his valuable contribution and wish him all the best for his future endeavors”. The Board of Directors has decided not to propose a successor for this position.

Direct link to the media release: http://also.com/goto/20190225en

Direct link to the annual report: http://also.com/goto/20190225ar

CONTACT:

For investors and financial media:

Alexandre Müller, Dynamics Group
+41 43 268 32 32
investor-relations@also.com

ALSO Holding AG (ALSN.SW) (Emmen/Switzerland) brings providers and buyers of the ICT industry together. ALSO offer more than 550 vendors of hardware, software and IT-services access to over 100 000 buyers, who can call a broad spectrum of other customized services in the logistics, finance, and IT services sectors, as well as traditional distribution services. From the development of complex IT landscapes, the provision and maintenance of hardware and software, right through to the return, reconditioning and remarketing of IT hardware, ALSO offers all services as a one-stop shop. ALSO is represented in 18 European countries and generates total net sales of approximately 9.2 billion euros with around 4 000 employees in the fiscal year 2018. The majority shareholder of ALSO Holding AG is the Droege Group, Düsseldorf, Germany. Further information is available at https://also.com.

Droege Group

Droege Group (founded in 1988) is an independent advisory and investment company under full family ownership. The company acts as a specialist for tailor-made transformation programs aiming to enhance corporate value. Droege Group combines its corporate family-run structure and capital strength into a family-equity business model. The group carries out direct investments with its own equity in corporate spin-offs and medium-sized companies in “special situations”. With the guiding principle “execution – following the rules of art”, the group is a pioneer in execution-oriented corporate development.

Droege Group follows a focused investment strategy based on current megatrends (knowledge, connectivity, prevention, demography, specialization, future work, shopping 4.0). Enthusiasm for quality, innovation and speed determines the company’s actions. In recent years Droege Group has successfully positioned itself in domestic and international markets and operates in 30 countries. More information: https://www.droege-group.com.

Disclaimer

This press release contains forward-looking statements which are based on current assumptions and forecasts of the ALSO management. Known and unknown risks, uncertainties, and other factors could lead to material differences between the forward-looking statements made here and the actual development, in particular the results, financial situation, and performance of our Group. The Group accepts no responsibility for updating these forward-looking statements or adapting them to future events or developments.

Additional features:

Document: http://n.eqs.com/c/fncls.ssp?u=XITFJGPHKG

SOURCE: ALSO Group

ReleaseID: 536819

TAMPA, FL / ACCESSWIRE / February 25, 2019 / PPJ Healthcare Enterprises, Inc. (OTC PINK: PPJE) today announced the retirement of 3,400,000,000 shares of common stock that has now been returned to treasury. This share retirement equates to a reduction of 44% of our currently outstanding common shares. PPJ CEO Chandana Basu stated, “This is the first of multiple steps we intend to take in regard to improving our share structure. As we continue to restructure, we will be looking to implement further strategies that will help build shareholder value.”

PPJ Healthcare Enterprises, Inc. also filed an amendment last week cancelling a previously announced reverse split as well as submitting this fiscal year annual report to remain active in the State of Florida. We will now be moving forward with updates to OTCmarkets with the goal of becoming current reporting in the near term. We look forward to sharing our goals for the future once we have completed the appropriate steps to bring the company back to good standing. Updates will continue to be made via our twitter page @PPJEnterprise as they become available. Our focus will remain on the long-term growth and prosperity of the company. Thank you to all shareholders for your continued support.

As always, PPJE management advises shareholders, company followers and prospective investors to contact their financial advisors if they have questions or concerns about their individual accounts and investment choices. Regarding other news and events, the company reminds its followers to monitor OTC Markets filings tab for further newsworthy events and corporate updates, which will follow as they happen (http://www.ppjenterprise.com).

Forward-looking Statements

Information in this release may contain statements about future expectations, plans, prospects or performance of PPJ Healthcare Enterprises Inc. that constitute forward-looking statements for purposes of the Safe Harbor Provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases ”can be,” ”expects,” ”may affect,” ”believed,” ”estimate,” ”project” and similar words and phrases are intended to identify such forward-looking statements. PPJ Healthcare Enterprises cautions you that any forward-looking information provided by or on behalf of PPJ Enterprise is not a guarantee of future performance. None of the information in this press release constituted or is intended as an offer to sell securities or investment advice of any kind. PPJ Healthcare Enterprises’ actual results may differ materially from those anticipated in such forward-looking statements because of various important factors, some of which are beyond PPJ Enterprise’s control. In addition to those discussed in PPJ Healthcare Enterprises’ press releases, public filings and statements by PPJ Healthcare Enterprises’ management, including, but not limited to, PPJ Healthcare Enterprises’ estimate of sufficiency of its existing capital resources, PPJ Healthcare Enterprises’ ability to raise additional capital to fund future operations, PPJ Healthcare Enterprises’ ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities, and in identifying contracts which match PPJ Healthcare Enterprises’ capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. PPJ Healthcare Enterprises does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made to reflect the occurrence of unanticipated events.

PPJ Healthcare Enterprises, Inc.

401 E. Jackson St., Suite 2340

Tampa, Florida 33602

Telephone: (813) 428-7514

Fax: (866) 622-3215

Websites: https://www.ppjenterprise.com

https://www.twitter.com/PPJEnterprise

SOURCE: PPJ Healthcare Enterprises, Inc.

ReleaseID: 536815

SAN FRANCISCO, CA / ACCESSWIRE / February 25, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX) (”Jaguar” or the ”Company”), a commercial stage pharmaceutical company focused on developing novel, sustainably derived gastrointestinal products on a global basis, today announced that its Special Meeting of Stockholders scheduled for February 25, 2019 (the “Special Meeting”) was adjourned to achieve a quorum on the proposals set forth in Jaguar’s definitive proxy statement on Schedule 14A, which was filed with the Securities and Exchange Commission (SEC) on January 18, 2019.

The Special Meeting has been adjourned to 8:30 a.m. Pacific Standard Time/11:30 a.m. Eastern Standard Time on Thursday, February 28, 2019, at the offices of the Company at 201 Mission Street, Suite 2375, San Francisco, CA 94105.

During the period of the adjournment, Jaguar will continue to solicit proxies from its stockholders with respect to the proposals set forth in the proxy statement. Only stockholders of record on the record date of January 10, 2019 are entitled to and are being requested to vote. If a stockholder has previously submitted its proxy card and does not wish to change its vote, no further action is required by such stockholder.

The Company encourages all stockholders who have not yet voted to do so before Thursday, February 27, 2019 at 11:59 p.m. (Pacific Standard Time).

How You Can Vote

The stockholders may vote by internet at www.investorvote.com/JAGX, or by telephone at 800-652-VOTE (8683) within the USA, US territories & Canada on a touch tone telephone, or by returning a properly executed proxy card.

No changes have been made to the proposals to be voted on by stockholders at the Special Meeting. The Company’s proxy statement and any other materials filed by the Company with the SEC remain unchanged and can be obtained free of charge at the SEC’s website at
www.sec.gov.

The Board and management of Jaguar recommend that you vote FOR the approval of each of the proposals before the stockholders at the Special Meeting.

Important Information

This material may be deemed to be solicitation material in respect of the solicitation of proxies from stockholders in connection with the Special Meeting. Jaguar has filed with the SEC and mailed to its stockholders a proxy statement in connection with the Special Meeting, and advises its stockholders to read the proxy statement and any and all supplements and amendments thereto because they contain important information. Stockholders may obtain a free copy of the proxy statement and other documents filed by Jaguar with the SEC at www.sec.gov. The proxy statement and proxy card are also available on the Company’s corporate website https://jaguar.health.

About Jaguar Health, Inc.

Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products on a global basis. Our wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Our Mytesi® (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

For more information about Jaguar, please visit jaguar.health. For more information about Napo, visit napopharma.com.

About Mytesi®

Mytesi (crofelemer) is an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy (ART). Mytesi is not indicated for the treatment of infectious diarrhea. Rule out infectious etiologies of diarrhea before starting Mytesi. If infectious etiologies are not considered, there is a risk that patients with infectious etiologies will not receive the appropriate therapy and their disease may worsen. In clinical studies, the most common adverse reactions occurring at a rate greater than placebo were upper respiratory tract infection (5.7%), bronchitis (3.9%), cough (3.5%), flatulence (3.1%), and increased bilirubin (3.1%).

See full Prescribing Information at Mytesi.com. Crofelemer, the active ingredient in Mytesi, is a botanical (plant-based) drug extracted and purified from the red bark sap of the medicinal Croton lechleri tree in the Amazon rainforest. Napo has established a sustainable harvesting program for crofelemer to ensure a high degree of quality and ecological integrity.

Forward-Looking Statements

Certain statements in this press release constitute ”forward-looking statements.” These include statements regarding the Company’s plan to hold a Special Meeting of Stockholders on Thursday, February 28, 2019. In some cases, you can identify forward-looking statements by terms such as ”may,” ”will,” ”should,” ”expect,” ”plan,” ”aim,” ”anticipate,” ”could,” ”intend,” ”target,” ”project,” ”contemplate,” ”believe,” ”estimate,” ”predict,” ”potential” or ”continue” or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to a number of risks, uncertainties and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar’s control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

Contact:

Peter Hodge
Jaguar Health, Inc.
phodge@jaguar.health
Jaguar-JAGX

SOURCE: Jaguar Health, Inc.

ReleaseID: 536782